[1] 王贵强, 段钟平, 王福生, 等. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020, 23(1):9-32. [2] Wu Y, Liu J, Feng Y, et al. Efficacy and safety of antiviral therapy for HBV in different trimesters of pregnancy: systematic review and network meta-analysis. Hepatol Int, 2020, 14(2):180-189. [3] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol, 2017, 67(2):370-398. [4] 赵蕾, 李小丹, 刘淼. 拉米夫定与替比夫定阻断乙型肝炎病毒宫内感染的疗效和风险分析. 实用肝脏病杂志, 2020, 23(4):496-499. [5] 范凌, 杨军, 纪风兵, 等. 妊娠中期应用替比夫定控制乙型肝炎病毒携带孕妇病毒载量及其阻断母婴传播效果分析. 实用肝脏病杂志, 2020, 23(2):179-182. [6] Chen CL, Yang JY, Lin SF, et al. Slow decline of hepatitis B burden in general population: results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol, 2015, 63(2):354-363. [7] Hou J, Wang G, Wang F, et al. Guideline of prevention and treatment for chronic hepatitis B (2015 update). J Clin Transl Hepatol, 2017, 5(4):297-318. [8] Ott JJ, Horn J, Krause G, et al. Time trends of chronic HBV infection over prior decades - a global analysis. J Hepatol, 2017, 66(1):48-54. [9] Zhaori G. Further standardization and safety issues for antiviral therapy during pregnancy. Pediatr Investig, 2020,4(2):148-149. [10] Hu Y, Yu H. Prevention strategies of mother-to-child transmission of hepatitis B virus (HBV) infection. Pediatr Investig, 2020, 4(2):133-137. [11] 郭茂, 罗文强, 张大志. 以母婴阻断为目的的抗乙型肝炎病毒药物治疗的停药时间.中华肝脏病杂志, 2019, 27(2):92-96. [12] Cheung KW, Seto MTY, Lao TT. Prevention of perinatal hepatitis B virus transmission. Arch Gynecol Obstet, 2019, 300(2):251-259. [13] 盛秋菊, 丁洋, 李佰君, 等. HBV感染免疫耐受期孕妇应用替比夫定阻断母婴传播有效性及停药安全性的研究. 中华肝脏病杂志, 2016, 24(4):258-264. [14] Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med, 2016, 374(24):2324-2334. [15] Lu FT, Ni YH. Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience. Pediatr Gastroenterol Hepatol Nutr, 2020, 23(4):311-318. [16] Song J, Yang F, Wang S, et al. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat, 2019, 26(3):397-406. [17] Brown RS Jr, McMahon BJ, Lok AS, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta-analysis. Hepatology, 2016,63(1):319-333. [18] Yi W, Li M, Xie Y, et al. Prospective cohort study on the efficacy and safety of telbivudine used throughout pregnancy in blocking mother‐to‐child transmission of hepatitis B virus. J Viral Hepat, 2017,24:49-56. [19] 郭辉杰, 高云飞, 刘惠媛. 妊娠期抗病毒治疗的慢性乙型肝炎病毒感染孕妇分娩时停药对产后肝功能的影响. 中华肝脏病杂志, 2019, 27(2):112-117. [20] Ren Y, Guo Y, Feng L, et al. Controversy and strategies exploration in blocking mother-to-child transmission of hepatitis B. Int Rev Immunol, 2016, 35:249-259. |